Cytokine Modulators
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (‘NSS’)
- Source
- OJEU
- Type
- Framework (Supply)
- Duration
- 2 year (est.)
- Value
- £116M
- Sector
- HEALTH
- Published
- 16 Feb 2021
- Delivery
- To 16 Feb 2023 (est.)
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
2 buyers
- NHS National Services Scotland NSS Edinburgh
11 suppliers
- Sandoz Camberley
- Pfizer Tadworth
- Biogen Idec Maidenhead
- Merck Sharp & Dohme Hoddesdon
- Celltrion Healthcare Slough
- Abbvie Maidenhead
- Amgen Cambrdige
- Fresenius Kabi Runcorn
- Accord Barnstaple
- Medac Pharma Stirling
- Nordic Pharma Theale
Description
Supply of Cytokine Modulators to NHS Scotland which is used to treat licensed indications. • etanercept, • Infliximab, • adalimumab, • methotrexate. The goods have been split into eight (8) categories, each of which are identified as a ‘Lot’. Full details of each lot are contained in section II.2) of this notice.
Lot Division
1 | Etanercept Supply of Etanercept to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to three (3) framework participants. |
2 | Infliximab IV Supply of Infliximab IV to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants. |
3 | Infliximab Subcutaneous Supply of Infliximab Subcutaneous to NHS Scotland. The authority has awarded this lot as a single supplier framework per line to one (1) framework participant. |
4 | Adalimumab Supply of Adalimumab to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to five (5) framework participants. |
5 | Methotrexate (50 mg per 1 ml Concentration) Pre-filled Self Injection Device Supply of methotrexate (50 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The Authority has awarded this Lot as a unranked multi-supplier framework per line to two (2) framework participants. |
6 | Methotrexate (50 mg per 1 ml Concentration) Pre-filled Syringes Supply of methotrexate (50 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. |
7 | Methotrexate (25 mg per 1 ml Concentration) Pre-filled Self Injection Device Supply of methotrexate (25 mg per 1 ml concentration) pre-filled self injection device to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. |
8 | Methotrexate (25 mg per 1 ml Concentration) Pre-filled Syringes Supply of methotrexate (25 mg per 1 ml concentration) pre-filled syringes to NHS Scotland. The authority has awarded this lot as a unranked multi-supplier framework per line to one (1) framework participant. |
Award Detail
1 | Sandoz (Camberley)
|
2 | Pfizer (Tadworth)
|
3 | Biogen Idec (Maidenhead)
|
4 | Pfizer (Tadworth)
|
5 | Merck Sharp & Dohme (Hoddesdon)
|
6 | Celltrion Healthcare (Slough)
|
7 | Biogen Idec (Maidenhead)
|
8 | Sandoz (Camberley)
|
9 | Celltrion Healthcare (Slough)
|
10 | Abbvie (Maidenhead)
|
11 | Amgen (Cambrdige)
|
12 | Fresenius Kabi (Runcorn)
|
13 | Biogen Idec (Maidenhead)
|
14 | Sandoz (Camberley)
|
15 | Accord (Barnstaple)
|
16 | Medac Pharma (Stirling)
|
17 | Accord (Barnstaple)
|
18 | Nordic Pharma (Theale)
|
19 | Nordic Pharma (Theale)
|
Award Criteria
Supply chain | 5.0 |
PRICE | 95.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Other Information
The estimated values referred to in Section II.I.5) and all lots cover the initial twenty four (24) month duration and the maximum twenty four (24) month extension period. (SC Ref:642734).
Reference
- OJEU 080986-2021